DEG enrichment of cell types in response to SD by autism risk genes, synaptic shaping component genes and DEGs from MEF2c loss of function or constitutive HD4 repression of MEF2c.
A) Heat map for cell type DEG enrichment by ASD risk genes, Synaptic Shaping Component genes, MEF2c- cKO DEGs and cnHD4 DEGs. B) Model for the control of sleep DEGs by HD4 repression of MEF2c and by pMEF2c during low sleep need (left). During high sleep need, MEF2c is de-repressed by sequestration of pHD4 to the cytoplasm and dephosphorylation of MEF2c. Both these events facilitate expression of sleep genes. C) It is proposed that SSC gene expression induced by prolonged waking or SD can, once asleep, decrease AMPA/NMDA ratio and increase silent synapses (SS) during sleep. This may bias glutamate synapses towards decreased strength but increased potential for LTP in preparation for the active phase, when sleep need is low. Conversely, as the active phase progresses, AMPA/NMDA ratio increases (as does synaptic strength), silent synapses are replaced by active synapses in association with increased expression of SSC genes to complete the cycle of glutamate, synapse, phenotype oscillation. D) An illustration of the SWS-SWA response to chronic MEF2c repression or activation. Chronic activation of MEF2c facilitated transcription leads to decreased AMPAR-mediated synaptic strength mimicking the effect of increased Ado tone, that will inhibit cortical-thalamic, glutamate synaptic activity to increase SWS-SWA. Chronic repression of MEF2c does the opposite, mimicking loss of ADORA1 function and tone, to decrease SWS-SWA.